ACell Announces CE Mark Approval
ACell Announces CE Mark Approval Milestone Paves the Way for MicroMatrix and Cytal Wound Management Devices in European Union News provided by Share this article Share this article COLUMBIA, Md., Dec. 22, 2020 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company, announced today that it has received CE mark approval for its MicroMatrix®, Cytal® Wound Matrix, and Cytal® Burn Matrix devices. This regulatory approval allows ACell to distribute these products throughout the 27 countries of the European Union. President and CEO Patrick McBrayer said, "The CE Mark approval is a...
Source: prnewswire.com